Calcium Acetate Shortage Update: What Patients Need to Know in 2026

If you take calcium acetate (PhosLo, Phoslyra, Eliphos, or Calphron) for high phosphate levels related to kidney disease, you may be wondering whether there is a shortage and what that means for your prescription. This post gives you the most up-to-date picture as of 2026.

Is There an Active FDA Shortage of Calcium Acetate in 2026?

As of 2026, calcium acetate does not appear on the FDA's active drug shortage list. The generic form is manufactured by multiple pharmaceutical companies and is widely available at major pharmacy chains. This is good news — unlike some other dialysis medications, calcium acetate has not experienced a declared national supply crisis.

However, the absence of an official FDA shortage does not mean it is always easy to find. Patients still run into out-of-stock situations regularly — particularly with brand-name versions and the oral liquid form. This is important to understand: a "no shortage" status means the overall supply is adequate nationally, not that every pharmacy near you will have it on any given day.

Why Patients Still Struggle to Find Calcium Acetate

Even without a national shortage, several real-world factors create localized availability gaps:

High consumption per patient. A single dialysis patient can use 200–400 tablets or capsules per month, depending on dosing. This high volume strains local pharmacy inventory.

Brand-name vs. generic gaps. PhosLo and Eliphos are no longer manufactured by all original producers. Some pharmacies may not stock branded versions, leading to confusion when a patient needs a specific brand.

Liquid form scarcity. Phoslyra (the oral solution) is prescribed for patients who cannot swallow pills. Very few retail pharmacies stock it routinely. Patients on the liquid form may always need to special-order it.

Rural and independent pharmacy limitations. Smaller pharmacies in rural areas may not order calcium acetate routinely because the local dialysis patient population is small. They may need to order it specially, causing a delay.

Manufacturer or distributor backorders. Even without an FDA-declared shortage, individual manufacturers occasionally experience temporary backorders that ripple through the supply chain.

Who Is Most Affected?

The patients most likely to be impacted by availability gaps are:

Patients prescribed a specific brand (PhosLo, Eliphos) rather than generic calcium acetate

Patients taking the oral liquid form (Phoslyra)

Patients in rural areas with limited pharmacy options

Patients whose insurance requires a specific brand or manufacturer

What Patients Should Do Right Now

Even if you are not currently experiencing a shortage, these steps will help protect your supply:

Refill early. Do not wait until your last few tablets. Refill when you have 7–10 days remaining.

Check your insurance requirements. Confirm whether your plan covers generic calcium acetate — this will dramatically expand your pharmacy options.

Speak with your nephrologist. If you are on brand-name PhosLo or Eliphos, ask if a switch to generic calcium acetate is appropriate for your situation.

Consider mail order. A 90-day mail-order supply through your insurance plan is often the most reliable way to maintain consistent access to calcium acetate.

Use medfinder. [@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop is a paid service that contacts pharmacies near you to check for current stock and texts you the results, so you can quickly find which locations have your medication without calling around yourself.

38,179+ patients found their medications in stock

38K+

Find Calcium Acetate In Stock Today →

What If You Run Out Completely?

If you run out of calcium acetate and cannot find it quickly, contact your nephrologist or dialysis center immediately. Do not simply skip your doses — even a few days without a phosphate binder can cause phosphate levels to spike dangerously. Your care team may be able to provide a short-term emergency supply or temporarily prescribe an alternative phosphate binder to bridge the gap.

How to Stay Informed About Shortages

You can check the FDA's drug shortage database at fda.gov/drugs for the latest official information. For more context on why availability gaps occur, read our post on why calcium acetate is hard to find. If you are looking for alternatives, see our guide to calcium acetate alternatives in 2026.